Improvement of C3A cell metabolism for usage in bioartificial liver support systems
- 31 October 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (4) , 599-605
- https://doi.org/10.1016/j.jhep.2004.06.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Early Experiences with a Porcine Hepatocyte-based Bioartificial Liver in Acute Hepatic Failure PatientsThe International Journal of Artificial Organs, 2002
- NEUROLOGICAL IMPROVEMENT DURING BIOARTIFICIAL LIVER SESSIONS IN PATIENTS WITH ACUTE LIVER FAILURE AWAITING TRANSPLANTATION1Transplantation, 2002
- What progress with artificial livers?The Lancet, 2001
- Liver transplantation for fulminant hepatic failure.The Esophagus, 2001
- Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systemsLiver Transplantation, 2001
- Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytesLiver Transplantation, 2000
- The management of acute liver failureAlimentary Pharmacology & Therapeutics, 1998
- Treatment of Severe Liver Failure with a Bioartificial LiveraAnnals of the New York Academy of Sciences, 1997
- Clinical Experience With a Bioartificial Liver in the Treatment of Severe Liver FailureAnnals of Surgery, 1997
- Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver FailureHepatology, 1996